As is the usual feature for class action lawsuits and consolidations, plaintiffs all appear to have similar complaints and allegations with regard to Levaquin (levofloxacin) and the potential for adverse effects involving tendons. Legal representatives close to the issue have suggested, according to AboutLawsuits.com, that there could literally be thousands of lawsuits citing similar complaints in the state of New Jersey alone.
Plaintiffs for Levaquin lawsuits claim the manufacturer, Ortho-McNeil-Janssen Pharmaceuticals, failed to research its product adequately prior to bringing Levaquin to market in 1996 and failed to warn about adverse effects to the tendon. Those side effects include tendonitis and tendon rupture, particularly involving the Achilles tendon.
In July of last year the US Food and Drug Administration (FDA) mandated a black box warning for levofloxacin and similar antibiotics with regard to tendon rupture and other tendon issues.
That warning came 12 years after Levaquin arrived.
In New Jersey, it is hoped that all Levaquin lawsuits will be centralized before Superior Court Judge Carol Higbee in Atlantic County. To that end the New Jersey Supreme Court has been asked to provide mass tort treatment.
READ MORE LEVAQUIN LEGAL NEWS
Levaquin is a robust antibiotic that has proven effective for fighting the various bacteria that causes infection. However, the Levaquin side effects that many experience have proven far worse than the health malady for which the Levaquin antibiotic was adopted in the first place. For some—John Fratti among them—the adverse reactions to Levaquin medicine have lasted far beyond the point at which the medication was stopped. The former pharmaceutical rep, still recovering from Levaquin-induced damage to his tendons and central nervous system, is waging a campaign to educate consumers as to the alleged perils of Levaquin.